jueves, 29 de abril de 2021

A troubled vaccine manufacturer, Emergent BioSolutions, announces a shake-up while projecting record revenues.


By BY SHERYL GAY STOLBERG AND CHRIS HAMBY from NYT World https://ift.tt/3nxovoJ

No hay comentarios:

Publicar un comentario